Cover image of the article: Possible Targets Related to Connexins and Ceramides in the Treatment of Depression Using a Combination Approach

Image Credit:J Rep Pharm Sci

Possible Targets Related to Connexins and Ceramides in the Treatment of Depression Using a Combination Approach

Authors

Amit Baban Avatade1, Pravin Kale1,*, Sachin S. Todkar2
1Department of Pharmacology, SVKM’s Dr. Bhanuben Nanavati College of Pharmacy, V. L. Mehta Road, Mithibai Campus, Vile Parle West, Mumbai 400056
2Department of Pharmaceutical Chemistry, Rajarambapu College of Pharmacy, Sangli, Maharashtra, India
*Corresponding Author: Corresponding author: Department of Pharmacology, SVKM’s Dr. Bhanuben Nanavati College of Pharmacy, V. L. Mehta Road, Mithibai Campus, Vile Parle West, Mumbai 400056. Email:pravinpkale@gmail.com

Journal of Reports in Pharmaceutical Sciences:Vol. 11, issue 1; 1-11
Published online:Jun 29, 2022
Article type:Review Article
Received:Mar 25, 2021
Accepted:Jan 29, 2022
How to Cite:Avatade AB, Kale P, Todkar SS. Possible Targets Related to Connexins and Ceramides in the Treatment of Depression Using a Combination Approach. J Rep Pharm Sci. 2022;11(1):e146129. doi: https://doi.org/10.4103/jrptps.JRPTPS_41_21

Abstract

The novel targets considered in the recent research related to the treatment of depression include connexins,
peroxisome proliferator activated receptor (PPAR), ω-3 fatty acids, ceramides, and renin–angiotensin–
aldosterone system (RAAS). The major associated brain parts considered include hypothalamus, pituitary,
and adrenal gland (HPA) axis in psychiatric disorders. The present review has proposed hypotheses such
as combining PPAR (α/γ) agonist with noradrenaline dopamine reuptake inhibitor, gap junction channel
modulator/hemichannel inhibitor with N-methyl-D-aspartate receptor antagonist like ketamine, ω-3 fatty
acids derivatives like resolvin with tricyclic antidepressant like amineptine, RAAS-modifying drugs
with serotonin reuptake inhibitors such as fluoxetine, ceramide synthase inhibitor/acid sphingomyelinase
inhibitor with doxepin, and HPA axis-modifying drugs with bupropion. Further assessment of these
combination approaches may help in availing better therapeutic options in the treatment of depression.

Highlights

Copyright

© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Oct
2017
Omega-3 Fatty acids as Monotherapy in Treating Depression in Pregnant Women: a Meta- Analysis of Randomized Controlled Trials

Omega-3 Fatty acids as Monotherapy in Treating Depression in Pregnant Women: a Meta- Analysis of Randomized Controlled Trials

Liu Wei-Hong,
Zhang Cheng-Gui,
Gao Peng-Fei,
Liu Heng,
Yang Jian-Fang

Wei-Hong L, Cheng-Gui Z, Peng-Fei G, Heng L, Jian-Fang Y. Omega-3 Fatty acids as Monotherapy in Treating Depression in Pregnant Women: a Meta- Analysis of Randomized Controlled Trials. Iran J Pharm Res. 2017;16(4):e125039. doi: https://doi.org/10.22037/ijpr.2017.2118

31
May
2026
Species-Specific Ceramide Modulation by Natural Compounds in Metabolic Syndrome and Cardiovascular Disease: Mechanistic and Emerging Lipidomic Insights

Species-Specific Ceramide Modulation by Natural Compounds in Metabolic Syndrome and Cardiovascular Disease: Mechanistic and Emerging Lipidomic Insights

Hassan Darvakh

Darvakh H. Species-Specific Ceramide Modulation by Natural Compounds in Metabolic Syndrome and Cardiovascular Disease: Mechanistic and Emerging Lipidomic Insights. Jundishapur J Nat Pharm Prod. 2026;21(2):e171497. doi: https://doi.org/10.5812/jjnpp-171497

31
Jul
2008
Beneficial Antipsychotic Effects of Omega-3 Fatty Acids Add-On Therapy for the Pharmacological Management of Patients With Schizophrenia

Beneficial Antipsychotic Effects of Omega-3 Fatty Acids Add-On Therapy for the Pharmacological Management of Patients With Schizophrenia

Ali Manteghiy,
Mohammad Taghi Shakeri,
Laleh Koohestani,
Elham Salari

Manteghiy A, Shakeri MT, Koohestani L, Salari E. Beneficial Antipsychotic Effects of Omega-3 Fatty Acids Add-On Therapy for the Pharmacological Management of Patients With Schizophrenia. Iran J Psychiatry Behav Sci. 2008;2(2):. doi:

1
Oct
2014
Discovery of the Endocannabinoid System: A Breakthrough in Neuroscience

Discovery of the Endocannabinoid System: A Breakthrough in Neuroscience

Parichehr Hassanzadeh

Hassanzadeh P. Discovery of the Endocannabinoid System: A Breakthrough in Neuroscience. Arch Neurosci. 2014;1(3):e15030. doi: https://doi.org/10.5812/archneurosci.15030

30
Jan
2007
The Public Health Impact of Antidepressant Medications

The Public Health Impact of Antidepressant Medications

Ramin Mojtabai

Mojtabai R. The Public Health Impact of Antidepressant Medications. Iran J Psychiatry Behav Sci. 2007;1(1):. doi:

More by these authors

Amit Baban AvatadePubMedScholar
Pravin KalePubMedScholar
Sachin S. TodkarPubMedScholar
Share
Cited by
Metrics